The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review
Abstract
L -2-Hydroxyglutaric aciduria (L -2-OHGA) is a rare autosomal recessive inherited encephalopathy. This inborn error, characterized by psychomotor retardation, progressive ataxia and typical magnetic resonance imaging findings, presents in early infancy. To make a definitive diagnosis, an anomalous accumulation of L -2-hydroxyglutaric acid must be detected in body fluids. Here, we present a 17-year-old boy with L: -2-OHGA who developed an anaplastic ependymoma during the course of this disease. We also present a literature review including seven other patients who developed malignant brain tumors during the course of L -2-OHGA. This correlation may indicate a possible increased risk of brain tumors among patients with L -2-hydroxyglutaric aciduria.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, patients with L-2-HGA are affected by tumors, including brain tumors93, bone tumors94, and nephroblastoma (Wilms tumor)95.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [93]
Citations
Cites
L‐2‐Hydroxyglutaric aciduria: an inborn error of metabolism?
Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H., & Wadman, S. K. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312543 · Cited by 226
L ‐2‐hydroxyglutaric acidemia: A novel inherited neurometabolic disease
Barth, P. G., Hoffmann, G. F., Jaeken, J., Lehnert, W., Hanefeld, F. A., Gennip, A. H., Durán, M., Valk, J., Schutgens, R. B. H., Trefz, F. K., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320111 · Cited by 151
Vaucher, E., Tong, X., Cholet, N., Lantin, S., & Hamel, É. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000529)421:2 · Cited by 126
L-2-hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition?
Moroni, I., Bugiani, M., D’Incerti, L., Maccagnano, C., Rimoldi, M., Bissola, L., Pollo, B., Finocchiaro, G., & Uziel, G. (2004) · Neurology · doi:10.1212/01.wnl.0000125335.21381.87 · Cited by 118
PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination
Frost, E. E., Nielsen, J. A., Le, T. Q., & Armstrong, R. C. (2003) · Journal of Neurobiology · doi:10.1002/neu.10158 · Cited by 116
Theodoropoulou, M., Arzberger, T., Grübler, Y., Jaffrain‐Rea, M., Schlegel, J., Schaaf, L., Petrangeli, E., Losa, M., Stalla, G. K., & Pagotto, U. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05616 · Cited by 105
Barbot, C., Fineza, I., Diogo, L. M., Maria, M., Melo, J., ̃es, A. G., Pires, M. M., Cardoso, M. L., & Vilarinho, L. (1997) · Brain and Development · doi:10.1016/s0387-7604(97)00574-3 · Cited by 87
Chen, E., Nyhan, W. L., Jakobs, C., Greco, C. M., Barkovich, A. J., Cox, V., & Packman, S. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799264 · Cited by 70
L-2-Hydroxyglutaric aciduria: MRI in seven cases
D’Incerti, L., Farina, L., Moroni, I., Uziel, G., & Savoiardo, M. (1998) · Neuroradiology · doi:10.1007/s002340050673 · Cited by 60
Clinical, biochemical and neuroradiological findings in L -2-hydroxyglutaric aciduria
Moroni, I., D’Incerti, L., Farina, L. M., Rimoldi, M., & Uziel, G. (2000) · Neurological Sciences · doi:10.1007/s100720070104 · Cited by 57
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–159 of 159
Metabolism of glioma and IDH1/IDH2 mutations
Rossetto, M., Ciccarino, P., Boisselier, B., Labussière, M., & Sanson, M. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.08.002 · Cited by 14
The Distribution and Significance of IDH Mutations in Gliomas
Mellai, M., Caldera, V., Annovazzi, L., & Schiffer, D. (2013) · InTech eBooks · doi:10.5772/52357 · Cited by 14
Impact of Genetic Targets on Primary Brain Tumor Therapy: What’s Ready for Prime Time?
Zalatimo, O. A., Zoccoli, C., Patel, A. P., Weston, C. L., & Glantz, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6176-0_12 · Cited by 12
Solomon, D. A., & Perry, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44941-0.00022-9 · Cited by 12
Something Old and Something New About Molecular Diagnostics in Gliomas
Horbinski, C. (2012) · Surgical pathology clinics · doi:10.1016/j.path.2012.09.001 · Cited by 13
WANG, J.-B., DONG, D.-F., Gao, K., & WANG, M.-D. (2014) · Oncology Letters · doi:10.3892/ol.2014.1806 · Cited by 11
Mutational analysis of D2HGDH and L2HGDH in brain tumours without IDH1 or IDH2 mutations
Brehmer, S., Pusch, S., Schmieder, K., von Deimling, A., & Hartmann, C. J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01114.x · Cited by 11
Zhao, H., Li, M., Du, P., Liao, X., Mo, X., Gong, M., Chen, J., & Liao, Y. (2024) · Biological Research · doi:10.1186/s40659-024-00512-2 · Cited by 11
Identification of novel L2HGDH mutation in a large consanguineous Pakistani family- a case report
Ullah, M. I., Nasır, A., Ahmad, A., Harlalka, G. V., Ahmad, W., Hassan, M. J., Baple, E. L., Crosby, A. H., & Chioza, B. A. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0532-x · Cited by 10
Biochemical control systems for small molecule damage in plants
Hüdig, M., Schmitz, J., Engqvist, M. K. M., & Maurino, V. G. (2018) · Plant Signaling & Behavior · doi:10.1080/15592324.2018.1477906 · Cited by 10
Scott, J. G., Basanta, D., Chinnaiyan, P., Canoll, P., Swanson, K. R., & Anderson, A. R. A. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor083 · Cited by 9
Analysis of Isocitrate Dehydrogenase 1 Mutation in 97 Patients with Glioma
Zhou, Y.-X., Wang, J., Feng, M., Sun, C., Sun, T., Chen, G., & Du, Z. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9681-5 · Cited by 9
Sonoda, Y., & Tominaga, T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.19 · Cited by 9
Augelli, R., Ciceri, E. F. M., Ghimenton, C., Zoccatelli, G., Bucci, A., Nicolato, A., Beltramello, A., Pinna, G., & Ricciardi, G. K. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.04.020 · Cited by 9
Kranendijk, M., Salomons, G. S., Gibson, K. M., Zeybek, A. Ç. A., Bekri, S., Christensen, E., Clarke, J. T. R., Hahn, A., Korman, S. H., Mejaški‐Bošnjak, V., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1282-x · Cited by 9
Intraventricular Glioblastoma Multiforme in A Child with L2-Hydroxyglutaric Aciduria
Tan, A. P., & Mankad, K. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.11.106 · Cited by 8
Komotar, R. J., Starke, R. M., Sisti, M. B., & Connolly, E. S. (2010) · Neurosurgery · doi:10.1227/01.neu.0000369899.41915.67 · Cited by 8
George, J., Sandhya, P., Sajitha, K., & Sundaram, S. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-244038 · Cited by 8
Rakheja, D., Khokhar, S., Mitui, M., & Cost, N. G. (2012) · Pediatric and Developmental Pathology · doi:10.2350/12-01-1151-oa.1 · Cited by 7
Shea, A., Risio, L. D., Carruthers, H., Ekiri, A. B., & Beltrán, E. (2016) · Veterinary Record · doi:10.1136/vr.103783 · Cited by 7
The mitochondrial proteome and human disease
Mootha, V. K. (2015) · Pathology · doi:10.1097/01.pat.0000461403.91531.dd · Cited by 7
L-2 hydroxyglutaric aciduria in a South African Staffordshire Bull Terrier
Böhm, M., Henderson, H., van der Zwan, H., & Basson, S. (2014) · Journal of the South African Veterinary Association · doi:10.4102/jsava.v85i1.1042 · Cited by 6
Zhang, Y., Wang, C., Yang, K., Wang, S., Tian, G., & Chen, Y. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3483-2 · Cited by 6
Adult High-Grade (Diffuse) Glioma
McNeill, K. A., Aldape, K., & Fine, H. A. (2014) · Molecular pathology library · doi:10.1007/978-1-4939-1830-0_6 · Cited by 5
Anomalies génétiques et moléculaires des glioblastomes (GBM)
Larsen, C. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1215 · Cited by 5
Clinical, Neuroimaging, and Genetic Features of the Patients with L-2-Hydroxyglutaric Aciduria
Canda, E. E., Köse, M., Yazıcı, H., Er, E., Eraslan, C., Özkınay, F., Çöker, M., Uçar, S. K., Habif, S., Karaca, E., et al. (2018) · The Journal of Pediatric Research · doi:10.4274/jpr.59454 · Cited by 5
Murphey, K., George, P. E., Pencheva, B., Porter, C. C., Wechsler, S. B., Gambello, M. J., & Li, H. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62891 · Cited by 2
L-2-hydroxyglutaric aciduria caused by a new mutation in the L2HGDH gene
Saifullina, E. V., Zakharova, E. Y., Kurkina, M. V., Magzhanov, R. V., Gaisina, E. V., & Закирова, Э. Н. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171174181-85 · Cited by 3
Molecular Pathology and Diagnostics of Gliomas
Kresak, J. L., & Shan, Y. (2013) · Springer eBooks · doi:10.1007/978-94-007-7192-5_1 · Cited by 3
The Role of Isocitrate Dehydrogenase Mutations in Glioma Brain Tumors
Chang, C.-M., Xu, K., & Hui-Kuo, G. (2011) · InTech eBooks · doi:10.5772/23238 · Cited by 3
Acidurie L-2-hydroxyglutarique : à propos de 2 cas
Wagner, S., Vianey‐Saban, C., Salomons, G. S., Schmitt, E., & Feillet, F. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2013.10.017 · Cited by 3
L-2-Hydroxyglutaric Aciduria and Brain Tumors
Coşkun, T. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181d74596 · Cited by 3
Cordier, F., Wesseling, P., Tops, B. B. J., Kester, L. A., French, P. J., van den Bent, M. J., Hinz, F. E., Aronica, E., Slot, K.-A. M., Abbink, F. C. H., et al. (2024) · Free Neuropathology · doi:10.17879/freeneuropathology-2024-5377 · Cited by 2
Rakheja, D. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181c67894 · Cited by 2
Zhang, M., Liu, Y. J., Lu, X., Du, L., He, N., Song, H., Wang, J., Gu, Y., Yang, M., Xu, C., et al. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31384 · Cited by 1
Lopez, C. P., Decena, S. V., Fonacier, K. G. D., & Chiong, M. A. D. (2017) · Acta Medica Philippina · doi:10.47895/amp.v51i3.571 · Cited by 1
Shimozato, M., Sakurai, T., Yaguchi, T., Shimohata, T., & Nishida, H. (2025) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-002026 · Cited by 1
Gliomagenesis: Advantages and Limitations of Biomarkers
Wager, M., Karayan, L., & Larsen, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0618-7_2 · Cited by 1
Transcription factors PROX1 and p53 in cancer development
Elsir, T. (2010) · Figshare · Cited by 1
Kranendijk, M. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
The Role of IDH1 and IDH2 Mutations in Malignant Gliomas
Sonoda, Y., Shibahara, I., Saito, R., Kumabe, T., & Tominaga, T. (2011) · Springer eBooks · doi:10.1007/978-94-007-0618-7_6
Lou, K.-J. (2009) · Science-Business eXchange · doi:10.1038/scibx.2009.1749
Contribution of Molecular Biology to the Classification of Low-Grade Diffuse Glioma
Ohgaki, H. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2213-5_5 · Cited by 1
Preface to the column "Metabolism of Childhood Cancer".
Rakheja, D. (2015) · PubMed Central · doi:10.3978/j.issn.2224-4336.2015.02.02
L2 Hidroksiglutarik Asidürili Bir Çocuk Olgu
Sunumu, O., & Çongar, E. Ç. (2012) · Acibadem University Open Access Repository
Dieter, R. S., Nanjundappa, A., Friedman, J. H., McCullough, P. A., Ebrahimi, R., Dalal, P., Yerram, P., Whaley‐Connell, A. T., Brandes, A. A., Dean, O. M., et al. (2012) · Clinical Practice · doi:10.2217/cpr.12.24
McCullough, P. A., & Dieter, R. S. (2013) · Clinical Practice · doi:10.2217/cpr.13.80
Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression
Kotredes, K. P. (2015) · TUScholarShare (Temple University)
A novel role for aconitase during erythroid development
Talbot, A.-L. (2011) · doi:10.18130/v3f55z
Pihlajaniemi, T. A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15637056
Prchal, J. T. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14143956.15779475
Faculty Opinions recommendation of Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
El‐Deiry, W. S., & van den Heuvel, P. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1168419.793462590
Oncometabolites and their role in cancer
Gill, E. L., Patel, K., & Rakheja, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824302-2.00003-5
Gupta, V. K., Sharma, N., Durden, B. C., Garrido, V. T., Kesh, K., Edwards, D., Wang, D., Myer, C., Mateo-Victoriano, B., Kollala, S. S., et al. (2023) · doi:10.1158/0008-5472.c.6513001.v1
L-2-Hydroxyglutaric Aciduria: An Ever-Expanding Phenotypic Spectrum
Kamath, S. D., Bhat, M. D., Santhosh, V., Arunachal, G., Prabhuraj, A. R., Kulanthaivelu, K., Ahmed, S., Asranna, A., & Kenchaiah, R. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_106_23
Loss of function variants in L2HGDH gene causing l-2-hydroxyglutaric aciduria
Bellad, A., Holla, V. V., Kumari, R., Kamble, N. L., Yadav, R., Pandey, A., Pal, P. K., & Muthusamy, B. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02318-7
Estudo de marcadores de diagnóstico e prognóstico em gliomas
Guedes, A. F. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zhao, H., Meng, L., Du, P., Liao, X., Mo, X., Gong, M., Chen, J., & Liao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25853177
Zhao, H., Meng, L., Du, P., Liao, X., Mo, X., Gong, M., Chen, J., & Liao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25853026
Metadata
- Authors
- Aghili, M., Zahedi, F., & Rafiee, E.
- Affiliations
- Imam Khomeini Hospital (IR)
- Corresponding author
- Aghili, Mahdi
- ORCID
- Aghili, Mahdi
- Venue
- Journal of Neuro-Oncology
- Published
- 2008-10-18
- Volume
- 91
- Issue
- 2
- Pages
- 233-236
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W2151358436
- Cited by
- 159
- References
- 14
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 12 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 12 · 2012: 18
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- L-2-hydroxyglutaric aciduria, malignant brain tumors, anaplastic ependymoma, inborn errors of metabolism, brain tumor risk, psychomotor retardation, ataxia
- MeSH terms
- Adolescent, Ependymoma, Frontal Lobe, Humans, Hydroxy Acids, Magnetic Resonance Imaging, Male, Brain Diseases, Metabolic, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review